Engineers Gate Manager’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,354
Closed -$67.6K 2002
2023
Q2
$67.6K Buy
20,354
+5,871
+41% +$17.4K ﹤0.01% 1604
2023
Q1
$30.8K Sell
14,483
-1,654
-10% -$4.09K ﹤0.01% 1576
2022
Q4
$43.4K Sell
16,137
-4,166
-21% -$12.2K ﹤0.01% 1562
2022
Q3
$66K Sell
20,303
-60,662
-75% -$274K ﹤0.01% 1475
2022
Q2
$395K Buy
80,965
+50,028
+162% +$308K 0.01% 1239
2022
Q1
$236K Buy
+30,937
New +$239K 0.01% 1546
2021
Q4
Sell
-19,780
Closed -$282K 2219
2021
Q3
$282K Buy
19,780
+6,880
+53% +$107K 0.02% 1233
2021
Q2
$214K Buy
+12,900
New +$240K 0.01% 1370

Other funds holding ORGO

Engineers Gate Manager's ORGO Position: Q3 2023 in Review

Engineers Gate Manager sold out of Organogenesis Holdings (ORGO) in Q3 2023, closing a stake of 20,354 shares — an estimated $67.6K sold.

Engineers Gate Manager first reported a position in ORGO in Q2 2021 and held it in 8 quarters. The position peaked at $395K in Q2 2022. 104 funds tracked by Wall St. Rank hold ORGO as of Q3 2023.

  • Engineers Gate Manager reported no remaining Organogenesis Holdings position as of Q3 2023 after selling out during the quarter.
  • Engineers Gate Manager sold 20,354 Organogenesis Holdings shares in Q3 2023, an estimated $67.6K.
  • Engineers Gate Manager first reported a position in Organogenesis Holdings in Q2 2021 and held it in 8 quarters.
  • Engineers Gate Manager's Organogenesis Holdings position peaked at $395K in Q2 2022.
  • 104 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2023.

Based on Engineers Gate Manager's 13F filing for Q3 2023, filed 14 Nov 2023.